16 Results for "

nonsense mutations

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "nonsense mutations" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-114231B
CAS No.: 2244622-33-9
Purity:  ≥98.0%
Synonyms: ELX-02 disulfate; NB-124 disulfate
Target:  

DNA/RNA Synthesis

Research Areas:  

Inflammation/Immunology

Exaluren (ELX-02; NB-124) disulfate is an synthetic eukaryotic ribosome-selective glycoside that induces read-through of nonsense mutations, resulting in normally localized full-length functional proteins. Exaluren disulfate is used for the research of cystic fibrosis caused by nonsense mutations .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-161111
CAS No.: 3056394-59-0
Target:  

Ser/Thr Kinase

Research Areas:  

Cancer

KVS0001 is a selective SMG1 inhibitor. KVS0001 elevates the expression of transcripts and proteins resulting from truncating mutations. KVS0001 increased the presentation of immune-targetable HLA class I-associated peptides from nonsense-mediated decay (NMD)-downregulated proteins on the surface of cancer cells. KVS0001 exerts anti-tumor properties and can be studied in research for NMD-related diseases, including cancer and inherited diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114231
CAS No.: 1375073-93-0
Synonyms: ELX-02; NB-124
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology

Exaluren (ELX-02; NB-124) is an synthetic eukaryotic ribosome-selective glycoside that induces read-through of nonsense mutations, resulting in normally localized full-length functional proteins. Exaluren is used for the research of cystic fibrosis caused by nonsense mutations .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101203
CAS No.: 1459687-89-8
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease Cancer

GJ103 is a read-through compound that can induce read through of premature stop codons. GJ103 has potential for the research of genetic disorders caused by nonsense mutations .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101203A
CAS No.: 1459687-96-7
Purity:  99.46%
Target:  

DNA/RNA Synthesis

Research Areas:  

Metabolic Disease Cancer

GJ103 sodium is a read-through compound that can induce read through of premature stop codons. GJ103 sodium has potential for the research of genetic disorders caused by nonsense mutations .
loading...
    loading...
Cat. No.: HY-159641
CAS No.: 3034880-93-5
Synonyms: BAY-3605349
VVD-130037 (BAY-3605349) is a covalent molecular glue and allosteric NRF2 degrader. VVD-130037 covalently binds to KEAP1 and allosterically enhances the affinity of KEAP1-CUL3, promotes the formation of the active KEAP1-CUL3 E3 ligase complex, and thereby enhances the ubiquitination and degradation of NRF2. VVD-130037 exhibits KEAP1 target-binding activity both in in vitro systems and mouse models, and it can be used in research related to NRF2-dependent cancers, solid tumors harboring KEAP1 nonsense mutations and frameshift mutations, as well as advanced solid tumors .
loading...
    loading...
Cat. No.: HY-118341
CAS No.: 105798-74-1
Purity:  ≥95.0%
Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity .
loading...
    loading...
Cat. No.: HY-150089
CAS No.: 883956-47-6
Purity:  99.21%
Target:  

CFTR

Research Areas:  

Inflammation/Immunology

SRI-37240 is a potent premature termination codons (PTCs) inhibitor. SRI-37240 suppresses CFTR nonsense mutations. SRI-37240 alters cellular translation termination at PTCs in HEK293T cells. SRI-37240 can also restore CFTR function in primary bronchial epithelial cells when combination with G418 .
loading...
    loading...
Cat. No.: HY-123359
CAS No.: 414909-09-4
Research Areas:  

Others

RTC14 is a read-through compound (RTC) that can induce ribosomes to bypass nonsense mutations in mRNA and allow the production of full-length functional proteins. RTC14 has the potential to be used in the research of various genetic disorders, such as nonsense mutations in the ataxia-telangiectasia mutated (ATM) gene and the dystrophin gene .
loading...
    loading...
Cat. No.: HY-177963
CAS No.: 2341941-41-9
Target:  

DNA Methyltransferase

Research Areas:  

Inflammation/Immunology

NV914 is an inhibitor of FTSJ1 (tryptophan tRNA-specific 2'-O-methyltransferase) that inhibits the methyltransferase activity of FTSJ1, induces translational readthrough of premature termination codons, and enables genes carrying nonsense mutations to synthesize full-length proteins. NV914 belongs to translational readthrough-inducing compounds (TRIDs). NV914 exhibits translational readthrough activity against nonsense mutations in in vitro systems, does not induce readthrough of natural termination codons, and restores CFTR protein expression. NV914 shows favorable acute oral tolerance in mice, with low health risks and good safety profiles. NV914 is applicable to research related to cystic fibrosis and Shwachman-Diamond syndrome .
loading...
    loading...
Cat. No.: HY-114231C
CAS No.: 1375073-94-1
Synonyms: ELX-02 sulfate; NB-124 sulfate
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease

Exaluren (ELX-02; NB-124) sulfate is an synthetic eukaryotic ribosome-selective glycoside that induces read-through of nonsense mutations, resulting in normally localized full-length functional proteins. Exaluren sulfate is used for the research of cystic fibrosis caused by nonsense mutations .
loading...
    loading...
Cat. No.: HY-177757
CAS No.: 1831092-94-4
Research Areas:  

Others

NVS2.1 is a potent, orally active and brain-penetrant readthrough promoter. NVS2.1 triggers the degradation of eRF1 by activating the ribosome-related quality control pathways (involving GCN1, RNF14, and RNF25), thereby facilitating the reading through of premature termination codons. NVS2.1 can be used for the research of genetic diseases caused by nonsense mutations .
loading...
    loading...
Cat. No.: HY-126210
CAS No.: 943092-47-5
Research Areas:  

Others

GJ072 is a read-through compound (RTCs). GJ072 can induce “readthrough” .
loading...
    loading...
Cat. No.: HY-157468
CAS No.: 1375073-95-2
Target:  

Others

Research Areas:  

Others

(R)-ELX-02, also referred to as NB-124, is an eukaryotic ribosomal selective glycoside (ERSG) engineered to enhance read-through activity in patients with nonsense mutations, facilitating the generation of adequate levels of full-length functional protein.
loading...
    loading...
Cat. No.: HY-118341R
CAS No.: 105798-74-1
H-Chpro-OH.HCl (Standard) is the analytical standard of H-Chpro-OH.HCl. This product is intended for research and analytical applications. H-Chpro-OH.HCl is a proline derivative .
loading...
    loading...
Cat. No.: HY-101203AR
CAS No.: 1459687-96-7
GJ103 (sodium) (Standard) is the analytical standard of GJ103 (sodium) (HY-101203A). This product is intended for research and analytical applications. GJ103 sodium is a read-through compound that can induce read through of premature stop codons. GJ103 sodium has potential for the research of genetic disorders caused by nonsense mutations .
loading...
    loading...
  • 1